Clinical Trials Browser

Observational × osimertinib × Clear all

NCT06477055 2026-04-13

RAISE

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT06538038 2026-03-27

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07491211 2026-03-27

Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases

Active not recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05103605 2025-12-01

POSITHES

Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06613633 2025-04-20

Third-generation EGFR-TKI Treatment in Metastatic EGFR-mutant NSCLC

Carcinoma, Non-Small-Cell Lung

NCT05834348 2025-03-30

DELINOR

5,279 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT06532149 2024-08-09

EROS

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

NCT05421936 2023-11-22

UNICORN

Carcinoma, Non-Small-Cell Lung

NCT04965701 2023-11-13

FLOWER

EGF-R Positive Non-Small Cell Lung Cancer

NCT04179890 2023-05-25

UpSwinG

462 enrolled 23 charts

Carcinoma, Non-Small-Cell Lung

NCT04391283 2023-03-17

First Line Osimertinib for EGFR Mutation-positive Non-Small Cell Lung Cancer in Real World Chinese Setting

Carcinoma, Non-Small-Cell Lung

NCT05513664 2022-08-24

Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT03790397 2022-06-03

OSIREX

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03219970 2021-09-14

Efficacy and Safety of Osimertinib for HK Chinese With Metastatic T790M Mutated NSCLC-real World Setting.

Carcinoma, Non-Small-Cell Lung

NCT03370770 2020-12-24

Afatinib Osimertinib Sequencing NIS

204 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT04575415 2020-10-20

BELLA

NSCLC

NCT03532698 2020-07-23

Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Carcinoma, Non-Small-Cell Lung

NCT03133234 2018-11-20

Effect of Osimertinib in Ethnic Chinese With EGFR and T790M Mutated NSCLC

T790M Positive NSCLC Patients